LAURUS LABS
Back to Balance Sheet
|
LAURUS LABS Last 5 Year Sundry Debtors History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Sundry Debtors | ₹2,155 Cr | ₹2,007 Cr | ₹1,663 Cr | ₹1,580 Cr | ₹1,354 Cr |
What is the latest Sundry Debtors ratio of LAURUS LABS ?
| Year | Sundry Debtors |
|---|---|
| Mar2026 | ₹2,155 Cr |
| Mar2025 | ₹2,007 Cr |
| Mar2024 | ₹1,663 Cr |
| Mar2023 | ₹1,580 Cr |
| Mar2022 | ₹1,354 Cr |
How is Sundry Debtors of LAURUS LABS Trending?
| Years | Sundry Debtors | % Change | |
|---|---|---|---|
| Mar2026 | ₹2,155 Cr | 7.37 | |
| Mar2025 | ₹2,007 Cr | 20.70 | |
| Mar2024 | ₹1,663 Cr | 5.22 | |
| Mar2023 | ₹1,580 Cr | 16.71 | |
| Mar2022 | ₹1,354 Cr | - | |
Compare Sundry Debtors of peers of LAURUS LABS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| LAURUS LABS | ₹104,453.5 Cr | 3.3% | 3.9% | 122.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹448,316.0 Cr | -1.9% | -3.7% | 18.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹251,737.0 Cr | 2.6% | 11.1% | 56% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹187,594.0 Cr | 0.2% | 1.3% | 38% | Stock Analytics | |
| CIPLA | ₹110,515.0 Cr | -1.5% | -6.4% | -12.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹95,420.6 Cr | -1% | -5.1% | -8.1% | Stock Analytics | |
LAURUS LABS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| LAURUS LABS | 3.3% |
3.9% |
122.8% |
| SENSEX | -2.4% |
-4.8% |
-7.2% |
You may also like the below Video Courses